Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Biological weapons Stories

WHO Reports On Ebolavirus, Emergency Response And Disease Transmission
2014-04-07 11:00:20

Lawrence LeBlond for redOrbit.com - Your Universe Online As of April 4, the Ministry of Health of Guinea has reported to the World Health Organization (WHO) 143 clinically compatible cases of infection from Ebolavirus disease (EVD). Of these, 54 have been laboratory confirmed by polymerase chain reaction (PCR). The total number of deaths associated with this outbreak stands at 86 – a case fatality rate of about 60 percent – of which sixteen have been lab-confirmed as EVD deaths, 65...

2014-03-10 12:25:52

PINE BROOK, N.J., March 10, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 13/076,082, granting a patent which covers methods of preventing or treating anthrax with ETI-204, the company's anti-anthrax antibody, together with antibiotics. The patent also...

2014-03-05 08:20:33

Hawaii Biotech Receives DoD Contract to Develop Anti-Botulism Drug HONOLULU, March 5, 2014 /PRNewswire/ -- The Department of Defense, Defense Threat Reduction Agency, has awarded Hawaii Biotech, Inc., a contract to continue developing drugs to block botulinum toxin, the toxin that causes the life-threatening disease, botulism. There is no therapeutic drug currently available for the treatment of botulism. The award has a first-year period of performance through early 2014, followed...

2014-02-20 12:00:18

A Kansas State University epidemiologist is helping cats, pet owners and soldiers stay healthy by studying feline tularemia and the factors that influence its prevalence. Ram Raghavan, assistant professor of diagnostic medicine and pathobiology, and collaborative researchers have found that a certain combination of climate, physical environment and socio-ecologic conditions are behind tularemia infections among cats in the region. More than 50 percent of all tularemia cases in the U.S....

2014-02-14 08:25:55

Soligenix Initiates Medical Countermeasure Development of SGX943 PRINCETON, N.J., Feb. 14, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases (NIAID) has...

2014-02-04 12:28:56

HONOLULU, Feb. 4, 2014 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded Hawaii Biotech, Inc. a grant to continue the development of anthrax anti-toxin drugs. The small molecule inhibitors under development block anthrax lethal toxin. The award has a first-year period of performance, through Q1 2014, valued at $1.1 million. The grant for the full five-year period equals $7.4 million. Under...

Sudan Reports Widespread Yellow Fever Outbreak, 14 Dead
2013-12-04 10:06:35

Lawrence LeBlond for redOrbit.com - Your Universe Online Sudan’s Federal Ministry of Health (FMOH) has notified the World Health Organization (WHO) of an outbreak of yellow fever that is affecting 12 localities in West and South Kordofan states. A total of 44 suspected cases and 14 deaths have been reported from October 3 to November 24, 2013 in the localities of Lagawa, Kailak, Muglad and Abyei in West Kordofan and Elreef Alshargi, Abu Gibaiha, Ghadir, Habila, Kadugli, Altadamon,...

2013-10-17 08:29:01

PRINCETON, N.J., Oct. 17, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today the formation of an international melioidosis Scientific Advisory Board (SAB). Comprised of clinicians and researchers from Australia, Thailand, Lao and The Netherlands with...

2013-09-25 08:29:06

PRINCETON, N.J., Sept. 25, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures (MCMs) where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (NIH) (specifically funded...

2013-09-16 08:28:10

PRINCETON, N.J., Sept. 16, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute...


Latest Biological weapons Reference Libraries

72_cefd267015c8eb1fc075a3a404bc6033
2011-04-15 15:02:18

Francisella tularensis is a pathogenic species of gram-negative bacteria and the causative agent of tularemia or rabbit fever. It is a facultative intracellular bacterium. It is classified as a Class A agent by the U.S. government due to its ease of spread by aerosol and its high virulence. In 1911 the species was found in ground squirrels in California. There are four subspecies that have been classified. Biovar tularensis is found mostly in North America. Biovar palearctica is found...

72_ee74f19d6ec18e594c4d7bc49406908f
2011-04-14 16:11:25

Burkholderia pseudomallei is a Gram-negative, bipolar, aerobic, motile rod-shaped bacterium. It causes the disease melioidosis in humans and animals and is also capable of infecting plants. The bacteria can from in a number of artificial environments. Optimal temperature is around 40°C in pH-neutral or slightly acidic environments. Most strains can ferment sugars without gas formation. The bacteria produces both exo and endo toxins although the role of these toxins has not been fully...

0_57c89d5bd133fff5bf10b17b705f87c1
2011-03-04 17:38:30

Yellow fever is an acute viral hemorrhagic disease with a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. It is transmitted by the bite of female mosquitoes and is found in tropical and subtropical areas in South America and Africa, but not in Asia. Primates and a few kinds of mosquitoes are the only known hosts. The origin of the disease is most likely Africa. From there it was introduced to South America through the slave trade in the 16th century. There...

70_d77407c28261963367e6668877b68dcb
2011-02-23 21:21:50

Venezuelan equine encephalitis virus is a mosquito-borne viral pathogen that causes Venezuelan equine encephalitis or encephalomyelitis (VEE). It can affect all equine species, such as horses, donkeys, and zebras. Equines may suddenly die or show progressive central nervous system disorders after infection. It is contractible by humans and will usually experience flu-like symptoms when infected. People with a weak immune system can become seriously ill or die. It is transmitted primarily...

45_4e5e02b08631498660875887f9638f27
2011-02-23 20:38:02

Rinderpest (also cattle plague) is an infectious viral disease of cattle, domestic buffalo, and some species of wildlife. It is characterized by fever, oral erosions, diarrhea, lymphoid necrosis, and high mortality. The last confirmed case was in 2001. In 2011 it should be announced that a global eradication of rinderpest was complete. The term comes from the German language meaning cattle-plague. The rinderpest virus is closely related to measles and canine distemper viruses. It is a...

More Articles (10 articles) »